A Synbiotic Infant Formula with High Magnesium Content Improves Constipation and Quality of Life
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the efficacy of synbiotic formula with partial whey hydrolysate and high magnesium content in infants presenting with functional constipation. Methods: Sixty-five infants with functional constipation were included. Forty infants were treated during one month with parental reassurance and the intervention formula and were compared to a control group of 25 infants treated with parental reassurance only. Parents completed a quality of life (QoL) questionnaire at baseline and during the last week of the study. Results: At inclusion, stool characteristics and QoL were similar in both groups. The control group was slightly older than the intervention group (7.5±3.9 vs. 6.2±3.6 weeks). At onset, stool composition was “hard and tight” (Bristol stool scale 1 and 2) in all infants. After one month, stool composition remained unchanged in the control group except in two infants that developed “creamy” stools (Bristol stool scale type 3 and 4). In the intervention group, stools re-mained “hard and tight” in 27.5%, and became “creamy” in 47.5%, “loose” (Bristol stool scale type 5) in 22.5% and “watery” (Bristol stool type 6 and 7) in 2.5%. The benefit of the intervention formula was estimated to be “very important”in 70%. The median scores for QoL improved significantly in the intervention group for all parameters and for one in the control group. Conclusion: The intervention formula significantly improved functional constipation resulting in a better QoL of the parents and infants.
Abstract
Purpose: To evaluate the efficacy of synbiotic formula with partial whey hydrolysate and high magnesium content in infants presenting with functional constipation. Methods: Sixty-five infants with functional constipation were included. Forty infants were treated during one month with parental reassurance and the intervention formula and were compared to a control group of 25 infants treated with parental reassurance only. Parents completed a quality of life (QoL) questionnaire at baseline and during the last week of the study. Results: At inclusion, stool characteristics and QoL were similar in both groups. The control group was slightly older than the intervention group (7.5±3.9 vs. 6.2±3.6 weeks). At onset, stool composition was “hard and tight” (Bristol stool scale 1 and 2) in all infants. After one month, stool composition remained unchanged in the control group except in two infants that developed “creamy” stools (Bristol stool scale type 3 and 4). In the intervention group, stools re-mained “hard and tight” in 27.5%, and became “creamy” in 47.5%, “loose” (Bristol stool scale type 5) in 22.5% and “watery” (Bristol stool type 6 and 7) in 2.5%. The benefit of the intervention formula was estimated to be “very important”in 70%. The median scores for QoL improved significantly in the intervention group for all parameters and for one in the control group. Conclusion: The intervention formula significantly improved functional constipation resulting in a better QoL of the parents and infants.
참고문헌 (14)
- Vandenplas Y, "Functional gastro-intestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies", Acta Paediatr, 105, pp.244~252 (2016)[DOI]
- Vandenplas Y, "Prevalence and health outcomes of functional gastrointestinal symptoms in infants from birth to 12 months of age", J Pediatr Gastroenterol Nutr, 61, pp.531~537 (2015)[DOI]
- Tabbers MM, "Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN", J Pediatr Gastroenterol Nutr, 58, pp.258~274 (2014)
- Benninga MA, "Childhood functional gastrointestinal disorders: neonate", toddler, 2016, pp.150, 1443~1455
- Tunc VT, "Factors associated with defecation patterns in 0-24-month-old children", Eur J Pediatr, 167, pp.1357~1362 (2008)[DOI]
- Hyams JS, "Effect of infant formula on stool characteristics of young infants", Pediatrics, 95, pp.50~54 (1995)
- Savino F, "Advances in the management of digestive problems during the first months of life", Acta Paediatr Suppl, 94, pp.120~124 (2005)[DOI]
- Bekkali NL, "The role of a probiotics mixture in the treatment of childhood constipation: a pilot study", Nutr J, 6, pp.17~ (2007)[DOI]
- Coccorullo P, "Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study", J Pediatr, 157, pp.598~602 (2010)[DOI]
- Guerra PV, "Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial", World J Gastroenterol, 17, pp.3916~3921 (2011)[DOI]
- Tabbers MM, "Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial", Pediatrics, 127, pp.1392~1399 (2011)[DOI]
- Izzo AA, "The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide", Magnes Res, 9, pp.133~138 (1996)
- Chao HC, "Therapeutic effect of Novalac-IT in infants with constipation", Nutrition, 23, pp.469~473 (2007)[DOI]
- Infante DD, "Modification of stool's water content in constipated infants: management with an adapted infant formula", Nutr J, 10, pp.55~ (2011)[DOI]